Source:http://linkedlifedata.com/resource/pubmed/id/12506121
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0000084,
umls-concept:C0015502,
umls-concept:C0079866,
umls-concept:C0596901,
umls-concept:C0806909,
umls-concept:C1514562,
umls-concept:C1552291,
umls-concept:C1552302,
umls-concept:C1627358,
umls-concept:C1880389,
umls-concept:C1883204,
umls-concept:C1883221,
umls-concept:C2349975,
umls-concept:C2752541
|
pubmed:issue |
10
|
pubmed:dateCreated |
2003-3-3
|
pubmed:abstractText |
Site-directed mutagenesis of the 40 N-terminal residues (gamma-carboxyglutamic acid domain) of blood clotting factor VII was carried out to identify sites that improve membrane affinity. Improvements and degree of change included P10Q (2-fold), K32E (13-fold), and insertion of Tyr at position 4 (2-fold). Two other beneficial changes, D33F (2-fold) and A34E (1.5-fold), may exert their impact via influence of K32E. The modification D33E (5.2-fold) also resulted in substantial improvement. The combined mutant with highest affinity, (Y4)P10Q/K32E/D33F/A34E, showed 150-296-fold enhancement over wild-type factor VIIa, depending on the assay used. Undercarboxylation of Glu residues at positions 33 and 34 may result in an underestimate of the true contributions of gamma-carboxyglutamic acid at these positions. Except for the Tyr(4) mutant, all other beneficial mutations were located on the same surface of the protein, suggesting a possible membrane contact region. An initial screening assay was developed that provided faithful evaluation of mutants in crude mixtures. Overall, the results suggest features of membrane binding by vitamin K-dependent proteins and provide reagents that may prove useful for research and therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
278
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8363-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12506121-1-Carboxyglutamic Acid,
pubmed-meshheading:12506121-Amino Acid Sequence,
pubmed-meshheading:12506121-Cell Membrane,
pubmed-meshheading:12506121-Factor VII,
pubmed-meshheading:12506121-Factor X,
pubmed-meshheading:12506121-Humans,
pubmed-meshheading:12506121-Molecular Sequence Data,
pubmed-meshheading:12506121-Mutagenesis, Site-Directed,
pubmed-meshheading:12506121-Sequence Homology, Amino Acid,
pubmed-meshheading:12506121-Spectrometry, Mass, Matrix-Assisted Laser...
|
pubmed:year |
2003
|
pubmed:articleTitle |
Mutagenesis of the gamma-carboxyglutamic acid domain of human factor VII to generate maximum enhancement of the membrane contact site.
|
pubmed:affiliation |
Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis 55455, USA.
|
pubmed:publicationType |
Journal Article
|